Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for prevention of postpartum depression after cesarean section
ChiCTR2200057213Phase 4Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial in postpartum depression (PPD) comparing dexmedetomidine with Control: placebo (normal saline) (2 arms). Primary endpoint: Incidence of postpartum depression. Planned start Jul 2022; status: not yet recruiting.
02
Drugs
dexmedetomidine
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on ChiCTR2200057213.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200057213.